Amedisys Stock In The News
| AMED Stock | USD 92.57 0.02 0.02% |
Our overall analysis of Amedisys' news coverage and content from conventional and social sources shows investors' bearish mood towards Amedisys. The specific impact of Amedisys news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Amedisys' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Amedisys headlines in addition to utilizing other, more conventional financial analysis modules. Check out Amedisys Backtesting and Amedisys Hype Analysis. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Amedisys |
Amedisys Today Top News and Investor Outlook
Amedisys Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Amedisys and other traded companies coverage with news coverage. We help investors stay connected with Amedisys headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Amedisys Stock performance. Please note that trading solely based on the Amedisys hype is not for everyone as timely availability and quick action are needed to avoid losses.
Amedisys stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Amedisys earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Amedisys that are available to investors today. That information is available publicly through Amedisys media outlets and privately through word of mouth or via Amedisys internal channels. However, regardless of the origin, that massive amount of Amedisys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amedisys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amedisys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amedisys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amedisys alpha.
Amedisys Largest EPS Surprises
Earnings surprises can significantly impact Amedisys' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2003-05-13 | 2003-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
2002-11-11 | 2002-09-30 | 0.08 | 0.1 | 0.02 | 25 | ||
2014-05-08 | 2014-03-31 | -0.04 | -0.07 | -0.03 | 75 | ||
2012-08-07 | 2012-06-30 | 0.24 | 0.27 | 0.03 | 12 | ||
2003-08-12 | 2003-06-30 | 0.09 | 0.12 | 0.03 | 33 | ||
2002-08-07 | 2002-06-30 | 0.16 | 0.13 | -0.03 | 18 |
Amedisys Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Amedisys Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
13th of March 2025
Acquisition by Nick Muscato of 5832 shares of Amedisys subject to Rule 16b-3 at MacroaxisInsider
6th of March 2025
Amedisys chief accounting officer sells 187,833 in stock - Investing.com India at news.google.com
3rd of March 2025
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises at zacks.com
27th of February 2025
Amedisys Reports Q4 Earnings What Key Metrics Have to Say at zacks.com
26th of February 2025
Amedisys Q4 Earnings Snapshot at finance.yahoo.com
24th of February 2025
Amedisys, Inc. Shares Acquired by South Dakota Investment Council at thelincolnianonline.com
21st of February 2025
UnitedHealth sinks on WSJ report of DoJ launching probe into Medicare practices at finance.yahoo.com
6th of February 2025
FY2026 EPS Estimates for Amedisys Raised by Leerink Partnrs - MarketBeat at news.google.com
27th of December 2024
UnitedHealth, Amedisys waive right to terminate merger pact UNHAMED at thefly.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amedisys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amedisys' short interest history, or implied volatility extrapolated from Amedisys options trading.
Check out Amedisys Backtesting and Amedisys Hype Analysis. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.35) | Earnings Share 1.31 | Revenue Per Share | Quarterly Revenue Growth 0.048 | Return On Assets |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.